Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Hair strength is similar across different scalp areas, and not affected by age, gender, or hair thickness.

Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Vitamin supplements may not improve hair thickness or density in patients with non-scarring hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Media attention increased oral minoxidil prescriptions for English-preferring patients but not for Spanish-preferring patients.

FUE hair transplantation effectively improves hair density and satisfaction in women with androgenetic alopecia.

Using a laser helmet with Minoxidil works better for male hair loss than Minoxidil alone, with no extra side effects.

New insights into cell communication in psoriasis suggest innovative drug treatments.

SLE and DM can coexist but are rare and need careful evaluation.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Low-dose oral minoxidil may be effective for hair loss treatment.

Zolpidem shows up in hair from the top back of the head after one dose and fades over time, suggesting it gets into hair through blood and sweat.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Females with idiopathic hirsutism have higher levels of omentin-1, which may lead to excessive hair growth.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

Chemical dyes damage hair's internal structure more than perming, as shown by a special imaging technique.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

PRP is an effective and safe treatment for hair loss in women.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Ionizing radiation causes irreversible skin damage, with single doses leading to acute injury and hair graying, and fractional doses causing more severe long-term tissue damage.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Retinoids may help treat lupus nephritis and reduce steroid use.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.